Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.38 - $0.64 $182,678 - $307,669
-480,734 Reduced 80.91%
113,441 $55,000
Q3 2021

Nov 16, 2021

BUY
$1.21 - $1.61 $24,422 - $32,496
20,184 Added 3.52%
594,175 $761,000
Q2 2021

Aug 16, 2021

BUY
$1.6 - $2.02 $42,060 - $53,101
26,288 Added 4.8%
573,991 $936,000
Q1 2021

May 17, 2021

BUY
$1.86 - $2.87 $104,652 - $161,480
56,265 Added 11.45%
547,703 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$1.65 - $2.43 $21,814 - $32,127
13,221 Added 2.76%
491,438 $1.02 Million
Q3 2020

Nov 13, 2020

SELL
$1.6 - $2.35 $14,324 - $21,039
-8,953 Reduced 1.84%
478,217 $818,000
Q2 2020

Aug 14, 2020

BUY
$1.33 - $2.76 $535,568 - $1.11 Million
402,683 Added 476.62%
487,170 $1.13 Million
Q4 2019

Feb 07, 2020

BUY
$1.69 - $3.8 $72,504 - $163,027
42,902 Added 103.17%
84,487 $322,000
Q2 2019

Aug 09, 2019

SELL
$0.51 - $0.86 $153,803 - $259,355
-301,576 Reduced 87.88%
41,585 $28,000
Q4 2018

Feb 14, 2019

SELL
$0.48 - $1.1 $64,033 - $146,743
-133,403 Reduced 27.99%
343,161 $166,000
Q2 2018

Aug 08, 2018

BUY
$1.56 - $2.51 $332,417 - $534,850
213,088 Added 80.88%
476,564 $744,000
Q3 2017

Nov 13, 2017

BUY
$1.55 - $1.82 $408,387 - $479,526
263,476
263,476 $467,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $173M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.